CANF vs ENLV: Side-by-Side Comparison
Compare Can-Fite Biopharma Ltd (CANF) and Enlivex Therapeutics Ltd (ENLV) side by side: market cap USD 5.12M vs USD 126.26M. Financials, growth and model signals on Bullrun.
| Metric | CANF | ENLV |
|---|---|---|
| Company | Can-Fite Biopharma Ltd | Enlivex Therapeutics Ltd |
| Country / Exchange | Israel · NYSE MKT | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 5.12M | USD 126.26M |
| P/E ratio | — | 0.0 |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 405.00K | — |
| Revenue growth YoY | -39.9% | — |
| Net income | USD -9.83M | USD 1.24B |
| Gross margin | — | — |
| Diluted EPS | -5.97 | 25.48 |